Clinical Research Directory
Browse clinical research sites, groups, and studies.
NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia
Sponsor: Martin Blomberg Jensen
Summary
This clinical interventional study aims to assess whether treatment with denosumab in combination with letrozole can improve sperm production in infertile men with non-obstructive azoospermia selected by serum anti-mullerian hormone (AMH) as a positive predictive biomarker.
Official title: Novel Treatment of Some Men With Non-Obstructive Azoospermia (NT-NOA): A Clinical Interventional Study
Key Details
Gender
MALE
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2025-03-01
Completion Date
2026-08
Last Updated
2025-12-01
Healthy Volunteers
Yes
Conditions
Interventions
Denosumab (Prolia)
Subcutaneous injection with 60 mg Denosumab once
Letrozole (Aromatase Inhibitors)
Letrozole oral tablet 2.5 mg once daily
Locations (1)
Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Herlev and Gentofte Hospital
Herlev, Denmark